Combined use of popular diabetes drugs likely to offer additional protection against heart and kidney disease

FHS
July 9, 2024
3:16 am

New research shows combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes.

New signaling pathway identified in aural migraine headaches

The rapid influx of cerebral spinal fluid (CSF) and protein solutes released during cortical spreading depression (CSD) in the brain activates neurons to trigger aural

July 5, 2024

iOmx Therapeutics Appoints Florian Schmid as New Chief Financial Officer – Biotech Investments

EQS-News: iOmx Therapeutics AG / Key word(s): Personnel iOmx Therapeutics Appoints Florian Schmid as New Chief Financial Officer 27.06.2024 / 10:00 CET/CEST The issuer is

June 28, 2024

Q&A: Trans adults face ‘shocking’ risk of cirrhosis, especially alcohol-driven

People under 45 have been driving an increase in liver-related deaths, especially those caused by alcohol. But a sliver of that young adult population is

July 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.